UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 149

Sortiert nach

Targeting SARS-CoV‑2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening

Journal of chemical information and modeling, 2021-02, Vol.61 (2), p.1020-1032

2021

Link zum Volltext

Verfügbarkeit prüfen

A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Molecular neurodegeneration, 2020-01, Vol.15 (1), p.1-1, Article 1

2020

Link zum Volltext

Verfügbarkeit prüfen

Basic Principles of Drug Discovery and Development

Blass, Benjamin E

1, 2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and Therapeutic Potential of the 5‑HT7 Receptor

ACS chemical neuroscience, 2019-01, Vol.10 (1), p.89-119

2019

Link zum Volltext

Verfügbarkeit prüfen

5-HT1B receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucrose

Frontiers in behavioral neuroscience, 2022-11, Vol.16, p.1020146-1020146

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction to: A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Molecular neurodegeneration, 2021-06, Vol.16 (1), p.1-42, Article 42

2021

Link zum Volltext

Verfügbarkeit prüfen

Dysfunction of the retromer complex system contributes to amyloid and tau pathology in a stem cell model of Down syndrome

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12334-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of Na v 1.7 for the Treatment of Pain

ACS medicinal chemistry letters, 2022-04, Vol.13 (4), p.532-533

Blass, Benjamin E

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of Nav1.7 for the Treatment of Pain

ACS medicinal chemistry letters, 2022-04, Vol.13 (4), p.532-533

Blass, Benjamin E

2022

Link zum Volltext

Verfügbarkeit prüfen

Cyclic ADP Ribose Hydrolase (CD38) Inhibitors

ACS medicinal chemistry letters, 2022-01, Vol.13 (1), p.13-14

Blass, Benjamin E

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats

Addiction neuroscience, 2023-03, Vol.5, p.100062, Article 100062

2023

Link zum Volltext

Verfügbarkeit prüfen

Pyrrolo-pyridazine Derivatives as Muscarinic M 1 Receptor Positive Allosteric Modulators

ACS medicinal chemistry letters, 2021-05, Vol.12 (5), p.677-678

Blass, Benjamin E

2021

Link zum Volltext

Verfügbarkeit prüfen

Pyrrolo-pyridazine Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators

ACS medicinal chemistry letters, 2021-05, Vol.12 (5), p.677-678

Blass, Benjamin E

2021

Link zum Volltext

Verfügbarkeit prüfen

The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats

Biomolecules (Basel, Switzerland), 2020-07, Vol.10 (7), p.1076

2020

Link zum Volltext

Verfügbarkeit prüfen

Carboxamides as Modulators of Sodium Channels

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2364-2365

Blass, Benjamin E

2020

Link zum Volltext

Verfügbarkeit prüfen

Novel Potassium Channel Inhibitors

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2357-2358

Blass, Benjamin E

2020

Link zum Volltext

Verfügbarkeit prüfen

2‑Amino-N-heteroaryl-nicotimamides as Nav1.8 Inhibitors

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2354-2356

Blass, Benjamin E

2020

Link zum Volltext

Verfügbarkeit prüfen

2-Amino-N-heteroaryl-nicotimamides as Na v 1.8 Inhibitors

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2354-2356

Blass, Benjamin E

2020

Link zum Volltext

Verfügbarkeit prüfen

Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype

Journal of Alzheimer's disease, 2023-01, Vol.91 (1), p.463

2023

Link zum Volltext

Verfügbarkeit prüfen

12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice

Biological psychiatry (1969), 2017-01, Vol.81 (2), p.92-100

2017

Link zum Volltext

Verfügbarkeit prüfen

Triazolo-azepine Inhibitors of γ‑Secretase and Their Methods of Use

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1243-1244

Blass, Benjamin E

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis

Medicinal research reviews, 2023-07, Vol.43 (4), p.872-896

2023

Link zum Volltext

Verfügbarkeit prüfen

Modulators of KEAP‑1 Activity as Potential Therapies for the Treatment of Neurodegenerative Disorders

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1245-1246

Blass, Benjamin E

2019

Link zum Volltext

Verfügbarkeit prüfen

Sodium Channel Modulators and Their Method of Use

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1247-1248

Blass, Benjamin E

2019

Link zum Volltext

Verfügbarkeit prüfen

Triazolo Pyridines Useful as Inhibitors of γ‑Secretase and Their Methods of Use

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1249-1250

Blass, Benjamin E

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(101)
Buchkapitel
(46)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting SARS-CoV‑2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening

A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Basic Principles of Drug Discovery and Development

Pharmacology and Therapeutic Potential of the 5‑HT7 Receptor

5-HT1B receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucrose

Correction to: A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Dysfunction of the retromer complex system contributes to amyloid and tau pathology in a stem cell model of Down syndrome

Inhibitors of Na v 1.7 for the Treatment of Pain

Inhibitors of Nav1.7 for the Treatment of Pain

Cyclic ADP Ribose Hydrolase (CD38) Inhibitors

HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats

Pyrrolo-pyridazine Derivatives as Muscarinic M 1 Receptor Positive Allosteric Modulators

Pyrrolo-pyridazine Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators

The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats

Carboxamides as Modulators of Sodium Channels

Novel Potassium Channel Inhibitors

2‑Amino-N-heteroaryl-nicotimamides as Nav1.8 Inhibitors

2-Amino-N-heteroaryl-nicotimamides as Na v 1.8 Inhibitors

Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype

12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice

Triazolo-azepine Inhibitors of γ‑Secretase and Their Methods of Use

Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis

Modulators of KEAP‑1 Activity as Potential Therapies for the Treatment of Neurodegenerative Disorders

Sodium Channel Modulators and Their Method of Use

Triazolo Pyridines Useful as Inhibitors of γ‑Secretase and Their Methods of Use

Suchergebnisse filtern